NCT04782713View on ClinicalTrials.gov

Smart Prostate Specific Antigen (PSA) Screening Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 17, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
PSAProstate Cancer
Interventions
OTHER

Completing surveys

Completing surveys at baseline, 3, 6, 9, and 12 months

Trial Locations (1)

60612

Mile Square Health Center, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER